Sendoxan Tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan tafla 50 mg

baxter medical ab* - cyclophosphamidum inn - tafla - 50 mg

Sertralin Bluefish Filmuhúðuð tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sertralin bluefish filmuhúðuð tafla 100 mg

bluefish pharmaceuticals ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Sendoxan Stungulyfsstofn, lausn 1 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 1 g

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g

Sendoxan Stungulyfsstofn, lausn 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sendoxan stungulyfsstofn, lausn 500 mg

baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg

Sertralin WH Filmuhúðuð tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sertralin wh filmuhúðuð tafla 50 mg

williams & halls ehf - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Zoloft Filmuhúðuð tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zoloft filmuhúðuð tafla 100 mg

upjohn eesv - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Zoloft Filmuhúðuð tafla 50 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zoloft filmuhúðuð tafla 50 mg

upjohn eesv - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Tibsovo Evrópusambandið - íslenska - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Æxlishemjandi lyf - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.